Thirty-Day Readmissions and Predictors of Adverse Outcomes After Bronchoscopic Lung Volume Reduction in the United States, 2019-2022.
Saved in:
| Title: | Thirty-Day Readmissions and Predictors of Adverse Outcomes After Bronchoscopic Lung Volume Reduction in the United States, 2019-2022. |
|---|---|
| Authors: | Patel M; Department of Internal Medicine, UTHealth Houston, Houston, TX, United States., Vijayan K; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Florida, Gainesville, FL, United States., Khamooshi P; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Florida, Gainesville, FL, United States., Burgei J; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Florida, Gainesville, FL, United States., Patel P; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Florida, Jacksonville, FL, United States., Mehta HJ; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Florida, Gainesville, FL, United States. |
| Source: | Annals of the American Thoracic Society [Ann Am Thorac Soc] 2026 Jun 24. Date of Electronic Publication: 2026 Jun 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Thoracic Society Country of Publication: England NLM ID: 101600811 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2325-6621 (Electronic) Linking ISSN: 23256621 NLM ISO Abbreviation: Ann Am Thorac Soc Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
